Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia.
D001238:Asphyxia Neonatorum / Q000188:drug therapy* / Q000401:mortality; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D009292:Narcotic Antagonists; D009270:Naloxone